Default company panoramic image

Retectix, LLC

Retectix, LLC is a medical device company producing nanofabricated surgical meshes offering superior handling and improved clinical outcomes

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded November 2010
  • Employees 5
  • Website

Company Summary

Retectix, LLC utilizes proprietary technology to produce nanofabricated surgical products for a variety of clinical applications. The initial offering in this line of products is the DuraStarTM Dural Substitute, a synthetic nanofabricated mesh for use in neurosurgical procedures. DuraStarTM provides superior handling properties, increased ease of use, improved biocompatibility, and reduced rates of complications compared to current products.


  • Default avatar
    Agnes Rey-Giraud

    Agnes recently retired from Express Scripts, Inc., where she served as President of International Operations. In her most recent role as President, International Operations, Agnes led the company’s movement into Asia. Agnès earned a Master of Science in Mechanical Engineering from Ecole Nationale d'Ingénieurs de Saint Etienne and an MBA from the University of Chicago.

  • Default avatar
    Matthew MacEwan
    President / CSO

    Matthew is an MD/PhD Candidate at Washington University School of Medicine in St. Louis, MO. Matthew has received multiple awards for his scientific and entrepreneurial work, including the 2012 Top 40 Under 40 in St. Louis (St. Louis Business Journal). Matthew graduated Summa Cum Laude with a degree in Biomedical Engineering from Case Western Reserve University in Cleveland, Ohio with a specialization in polymer biomaterials.

  • Default avatar
    Rhonda Soest
    VP, Sales + Marketing

    Rhonda is a clinician as well as a Marketing and Commercialization Executive who has successful leadership experience in Marketing, Operations, Business Development and Contract Negotiations. Rhonda has diverse product expertise in pharmaceutical, medical device and the biotechnology sectors. Prior to joining Retectix, LLC, Rhonda consistently delivered net sales and above target for OrthoBiotech, Inc., Johnson&Johnson, Inc., and Covidien, Inc.

  • Default avatar
    Julie Cochran
    Director, Business Development

    Julie served multiple roles in the biotechnology sector working at both McKinsey & Company, Inc., and Amgen, Inc. Julie earned a Bachelors of Science in Biomedical and Electrical Engineering at Duke University, and holds an MBA from the Stanford Graduate School of Business.

  • Default avatar
    Tamas Kovacs
    Project Manager

    Interested in driving operational efficiency, Tamás spent the last 2 years in China as a project manager for a Fortune 100 company within the healthcare services industry. After obtaining a bachelor’s degree in Operations Research and Industrial Engineering, Tamás went on to receive a master’s in Engineering Management, both degrees from Cornell University.


  • Default avatar
    Polsinelli Shughart, Global Patent Group
    Default avatar
    Rubin Brown

Previous Investors

  • Default avatar
    Washington University in St. Louis
    Default avatar
    Licensing Executives Society (LES)
    Default avatar
    Private Investment Group in St. Louis, MO